-
1Academic Journal
Πηγή: Биотехнология в растениеводстве, животноводстве и сельскохозяйственной микробиологии. :104-106
Θεματικοί όροι: СЕЛЬСКОЕ ХОЗЯЙСТВО, WATER ABSORBING POLYMERIC MATERIAL, АКРИЛОВЫЙ ГИДРОГЕЛЬ, AGRICULTURE, ВОДОПОГЛОЩАЮЩИЙ ПОЛИМЕРНЫЙ МАТЕРИАЛ, ACRYLIC HYDROGEL, CHITOSAN BASE, ОСНОВА ХИТОЗАНА
-
2Academic Journal
Συγγραφείς: Evgeny Kurbatskiy, Evgeny Titov, Olga Golosova, Sergey Kharitonov
Πηγή: Academia: Архитектура и строительство, Iss 1 (2020)
Θεματικοί όροι: 13. Climate action, Architecture, преобразование Фурье, финитные функции, целые функции, полимерный материал, скорости волн, сейсмоизоляция, виброизоляция, NA1-9428
-
3Academic Journal
Συγγραφείς: Снежана Александровна Хапёрских, Елена Сергеевна Ананьева
Πηγή: Ползуновский вестник, Iss 4, Pp 163-172 (2021)
Θεματικοί όροι: эпоксидно-диановая смола, эд-22, полиэтиленполиамин, пэпа, полимерный материал, твер-дость, истираемость, износ, адгезия, Technology
Περιγραφή αρχείου: electronic resource
Σύνδεσμος πρόσβασης: https://doaj.org/article/4e5aae5d03584eaf9d5c7a56047510df
-
4Academic Journal
Πηγή: Ползуновский вестник, Iss 1, Pp 179-186 (2021)
Θεματικοί όροι: эпоксидно-диановая смола, эд-22,полиэтиленполиамин, пэпа, полимерный материал, термический анализ, термопара, стеклование, гелеобразование, экзотермическая реакция, структурообразование, Technology
Περιγραφή αρχείου: electronic resource
Σύνδεσμος πρόσβασης: https://doaj.org/article/1ef74b029e2247d99167f5a271c027a4
-
5Academic Journal
Πηγή: Материалы XIX Всероссийской (национальной) научно-технической конференции студентов и аспирантов
Θεματικοί όροι: WOOD FLOUR, СТЕПЕНЬ АЦЕТИЛИРОВАНИЯ, АЦЕТАТ ЦЕЛЛЮЛОЗЫ, POLYMER MATERIAL, DEGREE OF ACETYLATION, CELLULOSE ACETATE, ПОЛИМЕРНЫЙ МАТЕРИАЛ, ДРЕВЕСНАЯ МУКА, PROPERTIES, СВОЙСТВА
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elar.usfeu.ru/handle/123456789/12226
-
6Academic Journal
Πηγή: Материалы XIV Международной научно-технической конференции
Θεματικοί όροι: СТЕПЕНЬ АЦЕТИЛИРОВАНИЯ, АЦЕТАТ ЦЕЛЛЮЛОЗЫ, POLYMER MATERIAL, DEGREE OF ACETYLATION, CELLULOSE ACETATE, ПОЛИМЕРНЫЙ МАТЕРИАЛ, СВОЙСТВА, PROPERTIES
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elar.usfeu.ru/handle/123456789/12009
-
7Academic Journal
Συγγραφείς: Усова, К. А., Шкуро, А. Е., Глухих, В. В.
Πηγή: Материалы XIX Всероссийской (национальной) научно-технической конференции студентов и аспирантов
Θεματικοί όροι: POLYMER MATERIAL, CELLULOSE ACETATE, DEGREE OF ACETYLATION, WOOD FLOUR, PROPERTIES, ПОЛИМЕРНЫЙ МАТЕРИАЛ, АЦЕТАТ ЦЕЛЛЮЛОЗЫ, СТЕПЕНЬ АЦЕТИЛИРОВАНИЯ, ДРЕВЕСНАЯ МУКА, СВОЙСТВА
Περιγραφή αρχείου: application/pdf
Relation: Научное творчество молодежи – лесному комплексу России : материалы XIX Всероссийской (национальной) научно-технической конференции студентов и аспирантов. – Екатеринбург, 2023; https://elar.usfeu.ru/handle/123456789/12226
Διαθεσιμότητα: https://elar.usfeu.ru/handle/123456789/12226
-
8Academic Journal
Συγγραφείς: Усова, К. А., Захаров, П. С., Шкуро, А. Е., Глухих, В. В.
Πηγή: Материалы XIV Международной научно-технической конференции
Θεματικοί όροι: ПОЛИМЕРНЫЙ МАТЕРИАЛ, АЦЕТАТ ЦЕЛЛЮЛОЗЫ, СТЕПЕНЬ АЦЕТИЛИРОВАНИЯ, СВОЙСТВА, POLYMER MATERIAL, CELLULOSE ACETATE, DEGREE OF ACETYLATION, PROPERTIES
Περιγραφή αρχείου: application/pdf
Relation: Эффективный ответ на современные вызовы с учетом взаимодействия человека и природы, человека и технологий: социально-экономические и экологические проблемы лесного комплекса : материалы XIV Международной научно-технической конференции; https://elar.usfeu.ru/handle/123456789/12009
Διαθεσιμότητα: https://elar.usfeu.ru/handle/123456789/12009
-
9Academic Journal
Συγγραφείς: Vera Anatol'yevna Loginova, Anna Vladimirovna Cheshkova, Irina Mikhaylovna Zakharova, Oskar Iosifovich Koyfman
Πηγή: chemistry of plant raw material; No 2 (2019); 27-34
Химия растительного сырья; № 2 (2019); 27-34Θεματικοί όροι: волокнистый полимерный материал, thermal oxidation, flax, лигнин, fibrous polymeric material, lignin, aluminosilicate, 02 engineering and technology, котонин, 7. Clean energy, cellulose, лен, термоокисление, cottonin (cotton-like fiber), алюмосиликат, целлюлоза, 0210 nano-technology
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://journal.asu.ru/cw/article/download/4529/4830
http://journal.asu.ru/cw/article/view/4529
https://cyberleninka.ru/article/n/termicheskie-harakteristiki-modifitsirovannyh-netkanyh-materialov-na-osnove-kotonina-lna
http://journal.asu.ru/cw/article/download/4529/4830
https://cyberleninka.ru/article/n/termicheskie-harakteristiki-modifitsirovannyh-netkanyh-materialov-na-osnove-kotonina-lna/pdf
http://journal.asu.ru/cw/article/view/4529 -
10Academic Journal
Πηγή: Ползуновский вестник, Iss 4, Pp 163-172 (2021)
Θεματικοί όροι: Technology, эпоксидно-диановая смола, эд-22, полиэтиленполиамин, пэпа, полимерный материал, твер-дость, истираемость, износ, адгезия
Σύνδεσμος πρόσβασης: https://doaj.org/article/4e5aae5d03584eaf9d5c7a56047510df
-
11Academic Journal
Θεματικοί όροι: поражения пленок, биоразрушение материалов, биоразлагаемый полимерный материал, упаковочные материалы, биоразрушение, биологически разлагаемая упаковка, компостирование
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elib.belstu.by/handle/123456789/41607
-
12Academic Journal
Πηγή: Ползуновский вестник, Iss 1, Pp 179-186 (2021)
Θεματικοί όροι: Technology, эпоксидно-диановая смола, эд-22,полиэтиленполиамин, пэпа, полимерный материал, термический анализ, термопара, стеклование, гелеобразование, экзотермическая реакция, структурообразование
Σύνδεσμος πρόσβασης: https://doaj.org/article/1ef74b029e2247d99167f5a271c027a4
-
13Academic Journal
Θεματικοί όροι: Plasma, Atomic force microscopy, Диэлектрический барьерный разряд, Surface energy, Polymer material, Атомная силовая микроскопия, Полимерный материал, Плазма, Шероховатость, Поверхностная энергия, Dielectric barrier discharge, Roughness
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elib.gstu.by/handle/220612/24193
-
14Academic Journal
Θεματικοί όροι: Оценка качества, Полимерный материал, Анализ
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elib.gstu.by/handle/220612/24204
-
15Academic Journal
Πηγή: Южно-Сибирский научный вестник.
Θεματικοί όροι: полимерный материал, бампер, oscillatory system, joint weld, колебательная система, automatic line, автоматизированная линия, ультразвуковая сварка, bumper, сварной шов, polymeric material, ultrasonic welding
-
16Academic Journal
Θεματικοί όροι: Горючесть, Полимерный материал, Комплексный показатель, Однофакторная математическая модель, Пожарная опасность, Антипирен
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://elib.gstu.by/handle/220612/21560
-
17Academic Journal
Συγγραφείς: A. S. Morozov, I. V. Bessonov, A. V. Nuzhdina, V. M. Pisarev, А. С. Морозов, И. В. Бессонов, А. В. Нуждина, В. М. Писарев
Πηγή: General Reanimatology; Том 12, № 6 (2016); 82-107 ; Общая реаниматология; Том 12, № 6 (2016); 82-107 ; 2411-7110 ; 1813-9779 ; 10.15360/1813-9779-2016-6
Θεματικοί όροι: экстракор поральная терапия, plasmasorbent, hemoperfusion, absorbing polymer material, sepsis, extracorporeal therapy, плазмосорбент, сорбирующий полимерный материал, сепсис
Περιγραφή αρχείου: application/pdf
Relation: https://www.reanimatology.com/rmt/article/view/1564/1074; https://www.reanimatology.com/rmt/article/view/1564/1110; Toshiaki I. Hemoadsorption in critical care. Ther. Apher. 2002; 6 (3): 189–192. http://dx.doi.org/10.1046/j.15260968.2002.00430.x.PMID: 12109941; Winchester J.F., Ronco C., Brady J.A., Clemmer J., Muller T.E., Davankov V., Tsyurupa M., Pavlova L., Pavlov M., Levin N.W. History of sorbents in uremia. Contrib. Nephrol. 2001; 133: 131–139. http://dx.doi.org/10.1159/000060120. PMID: 11477746; Ash S.R. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv. Ren. Replace Ther. 2002; 9 (1): 3–18. http://dx.doi.org/10.1053/jarr.2002.30474. PMID: 11927902; Winchester J.F., Salsberg J.A. Sorbents in the treatment of renal failure. Minerva Urol. Nefrol. 2004; 56 (3): 215–221. PMID: 15467500; Shoji H., Tani T., Hanasawa K., Kodama M. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther. Apher. 1998; 2 (1): 3–12. http://dx.doi.org/10.1111/j.17449987.1998.tb00066.x.PMID: 10227782; Ronco C. Endotoxin removal: history of a mission. Blood Purif. 2014; 37 (Suppl 1): 5–8. http://dx.doi.org/10.1159/000356831. PMID: 24457488; Ash S.R. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif. Organs. 1994; 18 (5): 355–362. http://dx.doi.org/10.1111/j.15251594.1994.tb02216.x. PMID: 8037609; Mitzner S.R., Stange J., Klammt S., Peszynski P., Schmidt R., Noldge Schomburg G. Extracorporeal detoxification using molecular adsorbent recirculating system for critically ill patients with liver failure. J. Am. Soc. Nephrol. 2001; 12 (Suppl 17): S75–S82. PMID: 11251037; Winchester J.F., Ronco C., Brady J.A., Cowgill L.D., Salsberg J., Yousha E., Choquette M., Albright R., Clemmer J., Davankov V., Tsyurupa M., Pavlova L., Pavlov M., Cohen G., HörlW., Gotch F., Levin N.W. The next step from highflux dialysis: application of sorbent technology. Blood Purif. 2002; 20 (1): 81–86. http://dx.doi.org/10.1159/000046989. PMID: 11803163; Geiger H., Klepper J., Lux P., Heidland A. Biochemical assessment and clinical evaluation of a bilirubin adsorbent column (BR350) in critically ill patients with intractable jaundice. Int. J. Artif. Organs. 1992; 15 (1): 35–39. PMID: 1551726; Tabei K., Akai Y., Takeda S., Homma S., Kusano E., Asano Y. Application of plasma perfusion in hepaticfailure. Biomater. Artif. Cells Immobilization Biotechnol. 1991; 19 (1): 193–201. http://dx.doi.org/10.3109/10731199109117826. PMID: 1751670; Mikhalovsky S.V. Microparticles for hemoperfusion and extracorporeal therapy. In: Arshady R. (ed.). Microspheres, microcapsules and liposomes. The MML Series, vol. 2: medical & biotechnology applications. London: Citus Books; 1999: 133–169.; Gordon A., Lewin A.J., Maxwell M.H., Roberts M. Current status of dialysate regeneration for the treatment of chronic uremia. In: Chang T.M.S. (ed.). Artificial kidney, artificial liver, and artificial cells. N.Y.: Plenum Press; 1978: 23–32. http://dx.doi.org/10.1007/9781468424782_4; Sangster B., van Heijst A.N.P., Sixma J.J. The influence of hemoperfusion on hemostasis and cellular constituents of the blood in the treatment of intoxications — a comparative study of 3 types of columns (Haemocol, Amberlite XAD4, Gambro Adsorba 300oC). Arch. Toxicol. 1981; 47 (4): 269–278. http://dx.doi.org/10.1007/bf00332393. PMID: 7271453; Clark W.T., III. Biocompatible hemoperfusion system. United States patent US4048064 (USA). 1977 Sept 13.; Cerulli N., La Greca G., Laville M., Palla R., Ramello A., Ghezzi P.M., Fouque D., Pizzarelli F., Schena F.P., Tetta C., Buades J., Camussi G., David S., Hoerl W., Triolo G., Maggiore U., Chiarulli G., Losurdo N., Petrarulo F., Sacchetti A., Pallotta G., Dagostino F., Del Mastro G., Sasdelli M., Mura C., Bongiorno P., Grill A., Varvara M., Carabellese S., Laraia E., Rizzi R., Mancini A., Losappio R., Maiorca R., Movilli E., Scolari F., Fiorini F., Imperatore P., Ranieri F., Bozzi M., Cuzzola R., De Min A., Specchio A., Bonomini M., Cuonzo M.T., Di Bari M., Dogliani M., Fidelio T., Ghezzi P.M., Meinero S., Canepari G., Surian M., Bonforte G., Rivera R., Sangalli L., Broccoli R., Maggiore Q., Pizzarelli F., Cavatorta F., Zollo A., Mastrangelo F., De Blasi V., Alfonso L., Usberti M., Rondina M., Laville M., Fouque D., Combarnous F., Basile C., Giordano R., Palla R., Betti G., Lopez T., Casino F., Ponticelli C., Valenti G., Ambroso G., Como G., di Belgioioso G.B., Bertoli S., Buzzi L., Albertazzi A., Lucchi L., Virgilio M., Giancaspro V., Pastore G., Conversano A., Testa A., Malcangi U., Reina E., Rusconi L., Meterangelis A., Amato M., Campolo G., Giachino G., Chiappero F., Carozzi S., Schelotto C., Sanna A., Stallone C., Aucella F., Ramello A., Marangella M., Vitale C., Quarello F., Formica M., Gastaldi L., Frattini G.M., Ervo R., Mij M., Baroni A., Borzumati M., Maschio G., Tessitore N., Loschiavo C., La Greca G., Brendolan A., Sessa A., Conte F., Ancarani E., Costantini S., Galliani M., Lorenz M., Robba C. The effect of hemodiafiltration with online endogenous reinfusion (online HFR) on anemia: design of a European, open, randomised, multicentre trial. J. Nephrol. 2000; 13 (1): 34–42. PMID: 10720212; Falkenhagen D., Strobl W., Hartmann T., Schrefl A., Linsberger I., Kellner K.H., Aussenegg Z., Leitner A. Patient safety technology extracorporeal for microadsorbent systems in blood purification. Artif. Organs. 2002; 26 (2): 84–90. http://dx.doi.org/10.1046/j.15251594.2002.06884.x. PMID: 11879234; Yu Y.T., Chen C.Z. Advances of adsorbents for hemoperfusion in China. Biomater. Artif. Cells Artif. Organs. 1990; 18 (4): 499–505. http://dx.doi.org/10.3109/10731199009119624. PMID: 2285812; Bansal R.C., Donnet J.B., Stoeckli F. (eds.). Active carbon. N.Y.: Marcel Dekker; 1988: 482.; Cipoletti J.J. Resin technology in medicine. In: Cipoletti J.J., Kunin R., Meyer F. Sorbents and their clinical applications. N.Y.: Academic Press; 1980: 221–248.; Афанасьева O.K., Алтынова Е.В., Болдырев А.Г., Соколов А.А., Адамова И.Ю., Покровский С.H. Сравнительный анализ эффективности и специфичности разных сорбентов для афереза липопротеидов низкой плотности. Бюл. эксперим. биологии и медицины. 2006; 142 (11): 532–536. http://dx.doi.org/10.1007/s1051700604254. PMID: 17415469; Yokoyama S., Hayashi R., Satani M., Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholes terolemia. Arteriosclerosis. 1985; 5 (6): 613–622. http://dx.doi.org/10.1161/01.atv.5.6.613. PMID: 3865648; Koll R.A. LDLTherasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy. Ther. Apher. 1998; 2 (2): 142–146. http://dx.doi.org/10.1111/j.17449987.1998.tb00092.x. PMID: 10225716; Bosch T. Recent advances in therapeutic apheresis. J. Artif. Organs. 2003; 6 (l): 1–8. http://dx.doi.org/10.1007/s100470300000. PMID: 14598117; Thompson G.R. LDL apheresis. Atherosclerosis. 2003; 167 (1): 1–13. http://dx.doi.org/10.1016/s00219150(02)002514. PMID: 12618263; NewsomDavis J. Autoimmunity in neuromuscular disease. Ann. N. Y. Acad. Sci. 1988; 540: 25–38. http://dx.doi.org/10.1111/j.17496632.1988.tb27048.x. PMID: 2849891; Bradl M., Lassmann H. Neurologic autoimmunity: mechanisms revealed by animal models. Handb. Clin. Neurol. 2016; 133: 121–143. http://dx.doi.org/10.1016/B9780444634320.000086. PMID: 27112675; Gilhus N.E., Skeie G.O., Romi F., Lazaridis K., Zisimopoulou P., Tzartos S. Myasthenia gravis — autoantibody characteristics and their implica tions for therapy. Nat. Rev. Neurol. 2016; 12 (5): 259–268. http://dx.doi.org/10.1038/nrneurol.2016.44. PMID: 27103470; Von Thun Und HohensteinBlaul N., Bell K., Pfeiffer N., Grus F.H. Autoimmune aspects in glaucoma. Eur. J. Pharmacol. 2016; 787: 105–118. http://dx.doi.org/10.1016/j.ejphar.2016.04.031. PMID: 27090926; Lally L., Sammaritano L.R. Vasculitis in antiphospholipid syndrome. Rheum. Dis. Clin. North Am. 2015; 41 (1): 109–123. http://dx.doi.org/10.1016/j.rdc.2014.09.009. PMID: 25399943; Conigliaro P., Chimenti M.S., Triggianese P., Sunzini F., Novelli L., Perricone C., Perricone R. Autoantibodies in inflammatory arthritis. Autoimmun. Rev. 2016; 15 (7): 673–683. http://dx.doi.org/10.1016/j.autrev.2016.03.003. PMID: 26970491; Sueoka A. Present status of apheresis technologies, part 3: adsorbent. Ther. Apher. 1997; 1 (3): 271–283. http://dx.doi.org/10.1111/j.17449987.1997.tb00150.x. PMID: 10225751; Hashimoto H., Tsuda H., Kanai Y., Kobayashi S., Hirose S., Shinoura H., Yokohari R., Kinoshita M., Aotsuka S., Yamada H., Takahashi K., Yoshiyama S., Miyamoto T. Selective removal of antiDNA and anticar diolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J. Rheumatol. 1991; 18 (4): 545–551. PMID: 2066947; Wiesenhuter C., Irish B., Bertram J. Treatment of patients with refractory rheumatoid arthritis with extracorporeal proteinA immunoadsorption column: a pilot trial. J. Rheumatol. 1994; 21 (5): 804–812. PMID: 8064718; Falson D.T., LaValley M.P., Baldassare A.R., Block J.A., Caldwell J.R., Cannon G.W., Deal C., Evance S., Fleischmann R., Gendreau R.M., Harris E.R., Matteson E.L., Roth S.H., Schumacher H.R., Weisman M.H., Furst D.E. The Prosorba column for treatment of refractory rheumatoid arthritis: A randomized, doubleblind, shamcontrolled trial. Arthritis. Rheum. 1999; 42 (10): 2153–2159. http://dx.doi.org/10.1002/15290131(199910)42:103.0.co;2w. PMID: 10524687; Braun N., Risler T. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease. Ther. Apher. 1999; 3 (3): 240– 245. http://dx.doi.org/10.1046/j.15260968.1999.00155.x. PMID: 10427622; Oka K., Nakaji S., Tanihara M., Takakura K., Takamori M. Development of specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis. Jpn. J. Artif. Organs. 1993; 22: 194–197.; Nakaji S., Oka K., Tanihara M., Takakura K., Takamori M. Development of a specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis. 1993. Ther. Apher. 2000; 4 (2): 124–126. http://dx.doi.org/10.1046/j.15260968.2000.004002124.x. PMID: 10805430; Koll R.A. IgTherasorb immunoadsorption for selective removal of human immunoglobulin diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins. Ther. Apher. 1998; 2 (2): 147–152. http://dx.doi.org/10.1111/j.17449987.1998.tb00093.x. PMID: 10225717; Kutsuki H., Takata S., Yamamoto K., Tani N. Therapeutic selective adsorption of antiDNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus. Ther. Apher. 1998; 2: 18–24. http://dx.doi.org/10.1111/j.17449987.1998.tb00068.x. PMID: 10227784; Pokrovsky S., Kuznetsova Yu.V., Afanasieva O.I., Zvezdkin P.V., Adamova I. Yu., Konovalov G.A. Clinical experience of immunoadsorption with ‘Ig Adsopak’ columns. Ther. Apher. Dial. 2005; 9 (5): A38. http://dx.doi.org/10.1111/j.17449987.2005.00324_4.x; Zahir F., Rabbani G., Khan R.H., Rizvi S.J., Jamal M.S., Abuzenadah A.M. The pharmacological features of bilirubin: the question of the century. Cell Mol. Biol. Lett. 2015; 20 (3): 418–447. http://dx.doi.org/10.1515/cmble20150012. PMID: 26208389; Qaisiya M., Brischetto C., Jašprová J., Vitek L., Tiribelli C., Bellarosa C. Bilirubininduced ER stress contributes to the inflammatory response and apoptosis in neuronal cells. Arch. Toxicol. 2016; [Epub ahead of print]. http://dx.doi.org/10.1007/s0020401618353. PMID: 27578021; Ahlfors C. Plasma bilirubin binding and bilirubin neurotoxicity. Dev. Med. Child Neurol. 2016; [Epub ahead of print]. http://dx.doi.org/10.1111/dmcn.13303. PMID: 27786370; Riordan S.M., Bittel D.C., Le Pichon J.B., Gazzin S., Tiribelli C., Watchko J.F., Wennberg R.P., Shapiro S.M. A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy. Front Neurosci. 2016; 10: 376. http://dx.doi.org/10.3389/fnins.2016.00376. PMID: 27587993; Watchko J.F. Bilirubininduced neurotoxicity in the preterm neonate. Clin. Perinatol. 2016; 43 (2): 297–311. http://dx.doi.org/10.1016/j.clp.2016.01.007. PMID: 27235209; Bhutani V.K., Wong R.J., Stevenson D.K. Hyperbilirubinemia in preterm neonates. Clin. Perinatol. 2016; 43 (2): 215–232. http://dx.doi.org/10.1016/j.clp.2016.01.001. PMID: 27235203; Amin S.B., Wang H., Laroia N., Orlando M. Unbound bilirubin and auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice. J. Pediatr. 2016; 173: 84–89. http://dx.doi.org/10.1016/j.jpeds.2016.02.024. PMID: 26952116; Wusthoff C.J., Loe I.M. Impact of bilirubininduced neurologic dysfunction on neurodevelopmental outcomes. Semin. Fetal. Neonatal. Med. 2015; 20 (1): 52–57. http://dx.doi.org/10.1016/j.siny.2014.12.003. PMID: 25585889; Olusanya B.O. Societal impact of bilirubininduced hearing impairment in resourcelimited nations. Semin. Fetal. Neonatal. Med. 2015; 20 (1): 58–63. http://dx.doi.org/10.1016/j.siny.2014.12.009. PMID:25573775; Gazzin S., Vitek L., Watchko J., Shapiro S.M., Tiribelli C. A novel perspective on the biology of bilirubin in health and disease. Trends Mol. Med. 2016; 22 (9): 758–768. http://dx.doi.org/10.1016/j.molmed.2016.07.004. PMID: 27515064; Tan H.K. Molecular Adsorbent Recirculating System (MARS). Ann. Acad. Med. Singapore. 2004; 33 (3): 329–335. PMID: 15175774; Collins K.L., Roberts E.A., Adeli K., Bohn D., Harvey E.A. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr. Nephrol. 2008; 23 (6): 1013–1016. http://dx.doi.org/10.1007/s004670080761x. PMID: 18299897; Mitzner S., Klammt S., Stange J., Schmidt R. Albumin regeneration in liver supportcomparison of different methods. Ther. Apher. Dial. 2006; 10 (2): 108–117. http://dx.doi.org/10.1111/j.17449987.2006.00351.x.PMID: 16684211; Takenaka Y. Bilirubin adsorbent column for plasma perfusion. Ther. Apher. 1998; 2 (2): 129–133. http://dx.doi.org/10.1111/j.17449987.1998.tb00090.x. PMID: 10225714; Nakaji S., Hayashi N. Bilirubin adsorption column Medisorba BL300. Ther. Apher. Dial. 2003; 7 (1): 98–103. http://dx.doi.org/10.1046/j.15260968.2003.00007.x. PMID: 12921123; Stegmayr B.G. Plasmapheresis in severe sepsis or septic shock. Blood Purif. 1996; 14 (1): 94–101. http://dx.doi.org/10.1159/000170250. PMID: 8718572; Stegmayr B.G. Is there a future for adsorption techniques in sepsis? Blood Purif. 2000; 18 (2): 149–155. http://dx.doi.org/10.1159/000014440. PMID: 10838475; Rimmelé T., Kellum J.A. Clinical review: blood purification for sepsis. Crit. Care. 2011; 15 (1): 205. http://dx.doi.org/10.1186/cc9411. PMID: 21371356; Воинов В.А. Эфферентная терапия критических состояний в реаниматологии. СПб.: СанктПетербургский ГМУ им. И.П.Павлова; 2013: 110.; Davies B., Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect. Dis. 2011; 11 (1): 65–71. http://dx.doi.org/10.1016/s14733099(10)702206. PMID: 21183148; Бажина Е.С., Никулин А.В., Хорошилов С.Е. Экстракорпоральные методы лечения абдоминального сепсиса. Общая реаниматология. 2015; 11 (5): 4566. http://dx.doi.org/10.15360/18139779201554566; Ушакова Н.Д., Шевченко А.Н., Четвериков М.В., Златник Е.Ю., Зыкова Т.А. Результаты применения селективной адсорбции эндотоксина при сепсисе у онкологических больных. Общая реаниматология. 2014; 10 (6): 32–38. http://dx.doi.org/10.15360/18139779201463238; Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther. Apher. Dial. 2003; 7 (1): 108–114. http://dx.doi.org/10.1046/j.15260968.2003.00005.x.PMID:12921125; Nakamura T., Kawagoe Y., Suzuki T., Shoji H., Ueda Y., Koide H. Polymyxin B–immobilized fiber hemoperfusion with the PMX05R column in elderly patients suffering from septic shock. Am. J. Med. Sci. 2007; 334 (4): 244–247. http://dx.doi.org/10.1097/MAJ.0b013e3180a5e8d8. PMID: 18030179; Toray Medical Co., Ltd. for endotoxin removal in patients with severe sepsis and septic shock. http://www.toraymedical.com/en/medical/kyusei/pdf/PMX20R.pdf; Kojika M., Sato N., Yaegashi Y., Suzuki Y., Suzuki K., Nakae H., Endo S. Endotoxin adsorption therapy for septic shock using polymyxin B immobilized fibers (PMX): evaluation by highsensitivity endotoxin assay and measurement of the cytokine production capacity. Ther. Apher. Dial. 2006; 10 (1): 12–18. http://dx.doi.org/10.1111/j.17449987.2006.00340.x. PMID: 16556131; Shoji H., Minaga M., Sakai Y., Kunitomo T., Takeyama T., Tani T., Kodama M. Design and development of endotoxin detoxifying column PMX and its clinical application. Jpn. J. Artif. Organs. 1993; 22 (1): 204–211.; Sakai Y., Shoji H., Kobayashi T., Terada R., Sugaya H., Murakami R., Moriyama K., Minaga M., Kunitomo N., Takeyama T. New extracorpo real blood purification devices for critical care medicine under devel opment. Ther. Plasmapheresis. 1993; 12: 837–842.; Shimizu T., Obata T., Sonoda H., Akabori H., Tabata T., Eguchi Y., Endo Y., Tani T. The ability of endotoxin adsorption during a longer duration of direct hemoperfusion with a polymyxin Bimmobilized fiber columnin patients with septic shock. Transfus. Apher. Sci. 2013; 49 (3): 499–503. http://dx.doi.org/10.1016/j.transci.2013.04.042. PMID: 23683501; Jaber B.L., Barrett T.W., Cendoroglo Neto M., Sundaram S., King A.J., Pereira B.J. Endotoxin removal by polymyxinB immobilized polystyrenederivative fibers during in vitro hemoperfusion of 10% human plasma. ASAIO J. 1998; 44 (1): 54–61. http://dx.doi.org/10.1097/0000248019980100000012. PMID: 9466502; Tani T., Hanasawa K., Kodama M., Imaizumi H., Yonekawa M., Saito M., Ikeda T., Yagi Y., Takayama K., Amano I., Shimaoka H., Ohta M., Okahisa T., Koga N., Fujita N., Yamasa H. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor1 activities in septic patients. World J. Surg. 2001; 25 (5): 660–668. http://dx.doi.org/10.1007/s002680020028. PMID: 11396436; Nakamura T., Sato E., Fujiwara N., Kawagoe Y., Maeda S., Yamagishi S. Suppression of highmobility group box1 and receptor for advanced glycation endproduct axis by polymyxin B–immobilized fiber hemop erfusion in septic shock patients. J. Crit. Care. 2011; 26 (6): 546– 549. http://dx.doi.org/10.1016/j.jcrc.2010.11.010. PMID: 21273029; Oishi K., MimuraKimura Y., Miyasho T., Aoe K., Ogata Y., Katayama H., Murata Y., Ueoka H., Matsumoto T., Mimura Y. Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine. 2013; 61 (1): 84–89. http://dx.doi.org/10.1016/j.cyto.2012.08.032. PMID: 23021430; Shimizu T., Hanasawa K., Sato K., Umeki M., Koga N., Naganuma T., Sato S., Shimonishi T., Ikeda T., Matsuno N., Ono S., Saitoh H., Satoh K., Otani Y., Endo Y., Eguchi Y., Tani T.; PMX Treatment Study Group in Septic Patients with Colorectal Perforation. The clinical significance of serum procalcitonin levels following direct hemoperfusion with polymyxin Bimmobilized fiber column in septic patients with colorectal perforation. Eur. Surg. Res. 2009; 42 (2): 109–117. http://dx.doi.org/10.1159/000187169. PMID: 19122457; Hanasawa K., Tani T., Oka T., Yoshioka T., Endo Y., Horisawa M., Nakane Y., Kodama M., Teramoto K., Nishiumi S. A new treatment for endotoxemia with direct hemoperfusion by polymyxin immobilized fiber. Ther. Apher. 2000; 4 (2): 142–145. http://dx.doi.org/10.1046/j.15260968.2000.004002142.x. PMID: 10805433; Tani T., Hanasawa K., Endo Y., Yoshioka T., Kodama M., Kaneko M., Uchiyama Y., Akizawa T., Takahasi K., Sugai K. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif. Organs. 1998; 22 (12): 1038– 1044. http://dx.doi.org/10.1046/j.15251594.1998.06086.x. PMID: 9876096; Kodama M., Hanasawa K., Tani T. Blood purification for critical care medicine: endotoxin adsorption. Ther. Apher. 1997; 1 (3): 224–227. http://dx.doi.org/10.1111/j.17449987.1997.tb00142.x. PMID: 10225743; Cruz D.N., Perazella M.A., Bellomo R., de Cal M., Polanco N., Corradi V., Lentini P., Nalesso F., Ueno T., Ranieri V.M., Ronco C. Effectiveness of polymyxin Bimmobilized fiber column in sepsis: a systematic review. Crit. Care. 2007; 11 (2): R47. http://dx.doi.org/10.1186/cc5780.PMID: 17448226; Nakamura T., Ebihara I., Shoji H., Ushiyama C., Suzuki S., Koide H. Treatment with polymyxin Bimmobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P selectin, platelet factor4 and betathromboglobulin. Inflamm. Res. 1999; 48 (4): 171–175. http://dx.doi.org/10.1007/s000110050442. PMID: 10344466; Nemoto H., Nakamoto H., Okada H., Sugahara S., Moriwaki K., Arai M., Kanno Y., Suzuki H. Newly developed polymyxin Bimmobilized fibers improve the survival of patients with sepsis. Blood Purif. 2001; 19 (4): 361–369. http://dx.doi.org/10.1159/000046966. PMID: 11574732; Nakamura T., Ushiyama C., Suzuki Y., Shoji H., Shimada N., Koide H. Hemoperfusion with polymyxinB immobilized fiber for urinary albumin excretion in septic patients with trauma. ASAIO J. 2002; 48 (3): 244–248. http://dx.doi.org/10.1097/0000248020020500000008. PMID: 12058997; Suzuki H., Nemoto H., Nakamoto H., Okada H., Sugahara S., Kanno Y., Moriwaki K. Continuous hemodiafiltration with polymyxin B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther. Apher. 2002; 6 (3): 234–240. http://dx.doi.org/10.1046/j.15260968.2002.00416.x. PMID: 12109950; Tsushima K., Kubo K., Koizumi T., Yamamoto H., Fujimoto K., Hora K., KanNou Y. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory. J. Clin. Apher. 2002; 17 (2): 97–102.http://dx.doi.org/10.1002/jca.10019. PMID: 12210714; Tsugawa K., Koyanagi N., Hashizume M., Wada H., Ayukawa K., Akahoshi K., Tomikawa M., Sugimachi K. Results of endotoxin absorption after a subtotal resection of the small intestine and a right hemicolectomy for severe superior mesenteric ischemia. Hepatogastroenterology. 2002; 49 (47): 1303–1306. PMID: 12239931; Nakamura T., Ushiyama C., Suzuki Y., Inoue T., Shoji H., Shimada N., Koide H. Combination therapy with polymyxin Bimmobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillinresistant Staphylococcus aureus. J. Hosp. Infect. 2003; 53 (1): 58–63. http://dx.doi.org/10.1053/jhin.2002.1332. PMID: 12495686; Nakamura T., Ushiyama C., Suzuki Y., Osada S., Inoue T., Shoji H., Hara M., Shimada N., Koide H. Hemoperfusion with polymyxinB immobilized fiber in septic patients with methicillinresistant Staphylococcus aureusassociated glomerulonephritis. Nephron. Clin. Pract. 2003; 94 (2): 33–39. http://dx.doi.org/10.1159/000071279. PMID: 12845235; Nakamura T., Matsuda T., Suzuki Y., Shoji H., Koide H. Polymyxin B immobilized fiber in patients with sepsis. Dial. Transplant. 2003; 32: 602–607.; Nakamura T., Kawagoe Y., Matsuda T., Koide H. Effect of polymyxin B immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med. 2004; 30 (9): 1838–1841. http://dx.doi.org/10.1007/s0013400423577. PMID: 15197430; Nakamura T., Kawagoe Y., Matsuda T., Ueda Y., Koide H. Effects of polymyxin Bimmobilized fiber on urinary NacetylBglu cosaminidase in patients with severe sepsis. ASAIO J. 2004; 50 (6): 563–567. http://dx.doi.org/10.1097/01.mat.0000142875.62592.3a. PMID: 15672789; Ono S., Tsujinomoto H., Matsumoto A., Ikuta S., Kinoshita M., Mochizuki H. Modulation of human leukocyte antigenDR on monocytes and CD16 on granulocytes in patients with polymyxin bimmobilized fiber. Am. J. Surg. 2004; 188 (2): 150–156. http://dx.doi.org/10.1016/j.amjsurg.2003.12.067. PMID: 15249240; Tsujimoto H., Ono S., Hiraki S., Majima T., Kawarabayashi N., Sugasawa H., Kinoshita M., Hiraide H., Mochizuki H. Hemoperfusion with polymyxin Bimmobilized fibers reduced the number of CD16+CD14+ monocytes in patients with septic shock. J. Endotoxin. Res. 2004; 10 (4): 229–237. http://dx.doi.org/10.1179/096805104225005814. PMID: 15373966; Nakamura T., Kawagoe Y., Sukuzi T., Shoji H., Ueda Y., Kobayashi N., Koide H. Changes in plasma interleukin18 by direct hemoperfusion with polymyxin Bimmobilized fiber in patients with septic shock. Blood Purif. 2005; 23 (6): 417–420. http://dx.doi.org/10.1159/000088016. PMID: 16141713; Vincent J.L., Laterre P.F., Cohen J., Burchardi H., Bruining H., Lerma F.A., Wittebole X., De Backer D., Brett S., Marzo D., Nakamura H., John S. A pilotcontrolled study of a polymyxin Bimmobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection. Shock. 2005; 23 (5): 400–405. http://dx.doi.org/10.1097/01.shk.0000159930.87737.8a. PMID: 15834304; Nakamura T., Ebihara I., Shimada N., Suzuki S., Ushiyama C., Shoji H., Koide H. Effects of hemoperfusion with polymyxin Bimmobilized fibre on serum neopterin and soluble interleukin2 receptor concentrations in patients with septic shock. J. Infect. 1998; 37 (3): 241–247. http://dx.doi.org/10.1016/s01634453(98)919521. PMID: 9892527; Nakamura T., Ebihara I., Shimada N., Koide H. Changes in plasma erythropoietin and interleukin6 concentrations in patients with septic shock after hemoperfusion and polymyxin Bimmobilized fiber. Intensive Care Med. 1998; 24 (12): 1272–1276. http://dx.doi.org/10.1007/s001340050761. PMID: 9885879; Nakamura T., Kawagoe Y., Matsuda T., Shoji H., Ueda Y., Tamura N., Ebihara I., Koide H. Effect of polymyxin Bimmobilized fiber on blood metalloproteinase9 and tissue inhibitor of metalloproteinase1 levels in acute respiratory distress syndrome patients. Blood Purif. 2004; 22 (3): 256–260. http://dx.doi.org/10.1159/000078494. PMID: 15148453; Shimada N., Nakamura T., Takayashi Y., Tanaka A., Shoji H., Sekizuka K., Ebihara I., Koide H. Effects of polymyxin Bimmobilized fiber on serum phosphate concentrations in patients with sepsis. Nephron. 2000; 86 (3): 359–360. http://dx.doi.org/10.1159/000045800. PMID: 11096302; Tojimbara T., Sato S., Nakajima I., Fuchinoue S., Akiba T., Teraoka S. Polymyxin Bimmobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure. Ther. Apher. Dial. 2004; 8 (4): 286–292. http://dx.doi.org/10.1111/j.15260968.2004.00166.x.PMID: 15274679; Ueno T., Sugino M., Nemoto H., Shoji H., Kakita A., Watanabe M. Effect over time of endotoxin adsorption therapy in sepsis. Ther. Apher. Dial. 2005; 9 (2): 128–136. http://dx.doi.org/10.1111/j.17749987.2005.00230.x. PMID: 15828924; Uriu K., Osajima A., Hiroshige K., Watanabe H., Aibara K., Inada Y., Segawa K., Anai H., Takagi I., Ito A., Kamochi M., Kaizu K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin Bimmobilized fiber ameliorates systemic circulatory distur bance in patients with septic shock. Am. J. Kidney Dis. 2002; 39 (5): 937–947. http://dx.doi.org/10.1053/ajkd.2002.32767. PMID: 11979337; Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M.; Early GoalDirected Therapy Collaborative Group. Early goaldirected therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 2001; 345 (19): 1368–1377. http://dx.doi.org/10.1056/nejmoa010307. PMID: 11794169; Ikeda T., Ikeda K., Nagura M., Taniuchi H., Matsushita M., Kiuchi S., Kuroki Y., Suzuki K., Matsuno N. Clinical evaluation of PMXDHP for hypercytokinemia caused by septic multiple organ failure. Ther. Apher. Dial. 2004; 8 (4): 293–298. http://dx.doi.org/10.1111/j.15260968.2004.00167.x. PMID: 15274680; Casella G., Monti G., Terzi V., Pulici M., Ravizza A., Vesconi S. Nonconventional therapies in refractory septic shock: clinical experience with Polymyxin B. Minerva Anestesiol. 2006; 72 (1): 63–67.; Follmann D., Elliott P., Suh I., Cutler J. Variance imputation for overviews of clinical trials with continuous response. J. Clin. Epidemiol. 1992; 45 (7): 769–773. http://dx.doi.org/10.1016/08954356(92)90054q. PMID: 1619456; Kushi H., Miki T., Okamoto K., Nakahara J., Saito T., Tanjoh K. Early haemoperfusion with an immobilized polymyxin B fiber column elimi nates humoral mediators and improves pulmonary oxygenation. Crit. Care. 2005; 9 (6): R653–R661. http://dx.doi.org/10.1186/cc3815.PMID: 16280061; Cruz D.N., Antonelli M., Fumagalli R., Foltran F., Brienza N., Donati A., Malcangi V., Petrini F., Volta G., Bobbio Pallavicini F.M., Rottoli F., Giunta F., Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009; 301 (23): 2445–2452. http://dx.doi.org/10.1001/jama.2009.856. PMID: 19531784; Vincent J.L. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA. 2009; 302 (18): 1967–1968. http://dx.doi.org/10.1001/jama.2009.1606. PMID: 19903915; Amaral A.C. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA. 2009; 302 (18): 1968–1970. http://dx.doi.org/10.1001/jama.2009.1607. PMID: 19903914; Kase Y., Obata T., Okamoto Y., Iwai K., Saito K., Yokoyama K., Takinami M., Tanifuji Y. Removal of 2arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. Ther. Apher. Dial. 2008; 12 (5): 374–380. http://dx.doi.org/10.1111/j.17449987.2008.00612.x. PMID: 18937720; Cantaluppi V., Assenzio B., Pasero D., Romanazzi G.M., Pacitti A., Lanfranco G., Puntorieri V., Martin E.L., Mascia L., Monti G., Casella G., Segoloni G.P., Camussi G., Ranieri V.M. PolymyxinB hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008; 34 (9): 1638–1645. http://dx.doi.org/10.1007/s0013400811246. PMID: 18463848; Kohro S., Imaizumi H., Yamakage M., Masuda Y., Namiki A., Asai Y., Maruyama I. Anandamide absorption by direct hemoperfusion with polymixin Bimmobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J. Anesth. 2006; 20 (1): 11–16. http://dx.doi.org/10.1007/s0054000503665. PMID: 16421670; Matsuno N., Ikeda T., Ikeda K., Hama K., Iwamoto H., Uchiyama M., Kozaki K., Narumi Y., Kikuchi K., Degawa H., Nagao T. Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure. Ther. Apher. 2001; 5 (1): 36–39. http://dx.doi.org/10.1046/j.15260968.2001.005001036.x. PMID: 11258608; Novelli G., Ferretti G., Poli L., Pretagostini R., Ruberto F., Perrella S.M., Levi Sandri G.B., Morabito V., Berloco P.B. Clinical results of treatment of postsurgical endotoxinmediated sepsis with polymyxinB direct hemo perfusion. Transplant. Proc. 2010; 42 (4): 1021–1024. http://dx.doi.org/10.1016/j.transproceed.2010.03.056. PMID: 20534214; Mori M., Onaka T., Yonezawa A., Kitagawa T., Sasaki Y., Imada K. Direct hemoperfusion using polymyxinB immobilized fiber for severe septic patients with hematological disorders: a singlecenter analysis. J. Infect. Chemother. 2014; 20 (4): 282–284. http://dx.doi.org/10.1016/j.jiac.2013.12.008. PMID: 24485325; Mitaka C., Fujiwara N., Yamamoto M., Toyofuku T., Haraguchi G., Tomita M. Polymyxin Bimmobilized fiber column hemoperfusion removes endotoxin throughout a 24hour treatment period. J. Crit. Care. 2014; 29 (5): 728–732. http://dx.doi.org/10.1016/j.jcrc.2014.03.031.PMID: 24798345; Klein D.J., Foster D., Schorr C.A., Kazempour K., Walker P.M., Dellinger R.P. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized con trolled trial. Trials. 2014; 15: 218. http://dx.doi.org/10.1186/1745621515218. PMID: 24916483; Cutuli S.L., Artigas A., Fumagalli R., Monti G., Ranieri V.M., Ronco C., Antonelli M.; EUPHAS 2 Collaborative Group. PolymyxinB hemoper fusion in septic patients: analysis of a multicenter registry. Ann. Intensive Care. 2016; 6 (1): 77. http://dx.doi.org/10.1186/s1361301601789. PMID: 27502196; Quenot J.P., Binquet C., Kara F., Martinet O., Ganster F., Navellou J.C., Castelain V., Barraud D., Cousson J., Louis G., Perez P., Kuteifan K., Noirot A., Badie J., Mezher C., Lessire H., Pavon A. The epidemiology of septic shock in French intensive care units: the prospective multicen ter cohort EPISS study. Crit. Care. 2013; 17 (2): R65. http://dx.doi.org/10.1186/cc12598. PMID: 23561510; Phua J., Koh Y., Du B., Tang Y.Q., Divatia J.V., Tan C.C., Gomersall C.D., Faruq M.O., Shrestha B.R., Gia Binh N., Arabi Y.M., Salahuddin N., Wahyuprajitno B., Tu M.L., Wahab A.Y., Hameed A.A., Nishimura M., Procyshyn M., Chan Y.H.; MOSAICS Study Group. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011; 342: d3245. http://dx.doi.org/10.1136/bmj.d3245. PMID: 21669950; Chihara S., MasudaY., Tatsumi H., Nakano K., Shimada T., Murohashi T., Yamakage M. Early induction of direct hemoperfusion with a polymyx inB immobilized column is associated with amelioration of hemody namic derangement and mortality in patients with septic shock. J. Artif. Organs. 2016; [Epub ahead of print]. http://dx.doi.org/10.1007/s1004701609229. PMID: 27469940; Kulabukhov V. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiol. Scand. 2008; 52 (7): 1024–1025. http://dx.doi.org/10.1111/j.13996576.2008.01677.x. PMID: 18494849; Adamik B., Zielinski S., Smiechowicz J., Kübler A. Endotoxin elimination in patients with septic shock: an observation study. Arch. Immunol. Ther. Exp. (Warsz.). 2015; 63 (6): 475– 483. http://dx.doi.org/10.1007/s0000501503488. PMID: 26093653; Mahlicli F.Y., Altinkaya S.A., Yurekli Y. Preparation and characterization of polyacrylonitrile membranes modified with polyelectrolyte deposition for separating similar sized proteins. J. Membr. Sci. 2012; 415–416 (1): 383–390. http://dx.doi.org/10.1016/j.memsci.2012.05.028; Honore P.M., Jacobs R., JoannesBoyau O., De Regt J., De Waele E., van Gorp V., Boer W., Verfaillie L., Spapen H.D. Newly designed CRRT membranes for sepsis and SIRS — a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic struc tured review. ASAIO J. 2013; 59 (2): 99–106. http://dx.doi.org/10.1097/MAT.0b013e3182816a75. PMID: 23438770; Mitzner S., Schneidewind J., Falkenhagen D., Loth F., Klinkmann H. Extracorporeal endotoxin removal by immobilized polyethylenimine. Artif. Organs. 1993; 17 (9): 775–781. http://dx.doi.org/10.1111/j.15251594.1993.tb00630.x. PMID: 8240070; Shum H.P., Chan K.C., Kwan M.C., Yan W.W. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gramnegative bacterial infection. Hong Kong Med. J. 2013; 19 (6): 491–497. http://dx.doi.org/10.12809/hkmj133910. PMID: 23650198; Bengsch S., Boos K.S., Nagel D., Seidel D., Inthorn D. Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock. 2005; 23 (6): 494–500. PMID:15897800; Гапанович В.Н., Кирковский В.В., Третьяк Д.С., Голубович В.П., Куцук О.Н., Старостин А.В., Мельнова Н.И., Андреев С.В. Антилипополисахаридный гемосорбент на основе сшитого полимиксина. Сообщение 1. Военная медицина. 2012; 3: 98–99.; Гапанович В.Н., Кирковский В.В., Третьяк Д.С., Голубович В.П., Андреев С.С., Мельнова Н.И., Жук И.Н. Антилипополисахаридный гемосорбент на основе сшитого полимиксина. Сообщение 2. Военная медицина. 2013; 2: 92–96.; Кирковский В.В., Гапанович В.Н., Третьяк Д.С., Старостин А.В., Добриянец А.И., Андреев С.В., Мельнова Н.И. Антилипополисахаридный гемосорбент на основе сшитого полимиксина. Сообщение 3. Военная медицина. 2013; 3: 97–100.; Скворцов Н.В., Власова О.Л., Болдырев А.Г., Ларионов И.В. Оценка эффективности сорбента Сфероцелл С80 в динамическом режиме. Научнотехнические ведомости СПбГПУ. Физикоматематические науки. 2015; 2: 91–98.; Скворцов Н.В., Самойлов В.О., Ларионов И.В., Болдырев А.Г. Эффективный сорбент для элиминации эндотоксина в биопрепаратах генноинженерного генеза и биологических жидкостях. Научно технические ведомости СПбГПУ. Физикоматематические науки. 2013; 3: 177–181.; http://toxipak.ru/column/about/; Payen D.M., Guilhot J., Launey Y., Lukaszewicz A.C., Kaaki M., Veber B., Pottecher J., JoannesBoyau O., MartinLefevre L., Jabaudon M., Mimoz O., Coudroy R., Ferrandière M., Kipnis E., Vela C., Chevallier S., Mallat J., Robert R.; ABDOMIX Group. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015; 41 (6): 975–984. http://dx.doi.org/10.1007/s001340153751z. PMID: 25862039; Sugiura M., Mitaka C., Haraguchi G., Tomita M., Inase N. Polymyxin B immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock. J. Intensive Care. 2015; 3 (1): 14. http://dx.doi.org/10.1186/s4056001500809. PMID: 25866644; Davankov V., Pavlova L., Tsyurupa M., Brady J., Balsamo M., Yousha E. Polymeric adsorbent for removing toxic proteins from blood of patients with kidney failure. J. Chromatogr. B. Biomed. Sci. Appl. 2000; 739 (1): 73–80. http://dx.doi.org/10.1016/s03784347(99)00554x. PMID: 10744315; https://www.reanimatology.com/rmt/article/view/1564
-
18Academic Journal
Συγγραφείς: А. В. Славгородский
Θεματικοί όροι: гербарий, гербарный пресс, спанбонд, нетканый полимерный материал, сушка растений
Περιγραφή αρχείου: text/html
-
19Academic Journal
-
20Academic Journal
Συγγραφείς: Mozgovoj, V, Kashan, A, Panasenko, V
Πηγή: Herald of Aeroenginebuilding; № 1 (2017): Herald of aeroenginebuilding
Вестник двигателестроения; № 1 (2017): Вестник двигателестроения
Вісник двигунобудування; № 1 (2017): Вісник двигунобудуванняΘεματικοί όροι: панель шумоглушения, авиационный двигатель, полимерный материал,износ, скорость резания, станок с ЧПУ, сверло, шероховатость, подача, фреза, отклонение, углепластик, эмульсия, инструмент, роутер, расслоение композиционного материала, подача на зуб, твердый сплав, быстрорежущая сталь, The panel sound-suppressing, the aviation engine, a polymeric material, deterioration, speed of cutting, the machine CNC, a mill, a drill, a roughness, giving, a deviation, coal plastic, emulsion, the tool, a router, stratification of a composite material, giving on tooth, a firm alloy, a fa
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://vd.zntu.edu.ua/article/view/114097